Friday 22 November, 2019
Edition: English (US)
Tag Archives: Pharmacyte Biotech Inc

Clinical stage biotechnology firm Pharmacyte Biotech Inc (OTCMKTS:PMCB) announced on Thursday that David A. Judd is the latest executive to join its Medical and Scientific Advisory board. The company believes that Judd is a great addition...

By Steven Russell on Jul 18th, 2019

Mr. David Judd, a consultant cellular biologist, and Chief Executive Officer of Pharmacyte Biotech Inc (OTCMKTS:PMCB), Kenneth L. Waggoner will visit the GMP production facility of Austrianova in Bangkok, Thailand. They will oversee the production...

By Steven Russell on Jun 12th, 2019

Pharmacyte Biotech Inc (OTCMKTS:PMCB) currently working on its Investigational New Drug application and has sought the expertise of cGMP Validation to ensure that they submit a flawless masterpiece to the U.S Food and Drug Administration (FDA)...

By Jaime Williams on Dec 6th, 2018

In the last trading session, the stock price of PharmaCyte Biotech Inc (OTCQB:PMCB) declined more than 5% to close the day at $0.06. The decline came at a share volume of 2.83 million compared to average share volume of 2.38 million. PMCB has...

By David Rees on Dec 19th, 2017
Pharmacyte Biotech Inc

Pharmacyte Biotech Inc (OTCMKTS:PMCB) announced that Eurofins Lancaster Laboratories, a major Contract Manufacturing Organization that company selected to set its Master Cell Bank, has successfully concluded its independent growth assessment...

By Jaime Williams on Dec 1st, 2017

Pharmacyte Biotech Inc (OTCMKTS:PMCB) reported that its senior management will attend the annual meeting of the ASCO. The theme of this meeting is focused on bringing a difference in cancer care. Kenneth L. Waggoner, the CEO, reported that this...

By Brandon Manns on Jun 5th, 2017